|
|
|
Insider
Information: |
Saxe Jon S |
Relationship: |
|
City: |
Cupertino |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
572,241 |
|
Indirect Shares
|
200,000 |
|
|
Direct
Value |
$5,756,255 |
|
|
Indirect Value
|
$397,500 |
|
|
Total
Shares |
772,241 |
|
|
Total
Value |
$6,153,755 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
211.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Durect Corp |
DRRX |
Director |
2019-06-10 |
27,810 |
2019-06-10 |
150,000 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2004-03-30 |
80,000 |
2004-03-30 |
0 |
Premium* |
|
PDL Biopharma Inc |
PDLI |
Director |
2008-04-09 |
421,680 |
2004-11-01 |
0 |
Premium* |
|
Insite Vision Inc |
INSV |
Director |
2007-09-13 |
37,000 |
2007-09-13 |
0 |
Premium* |
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2017-10-13 |
0 |
2007-11-20 |
0 |
Premium* |
|
Vistagen Therapeutics Inc |
VTGN |
|
2021-03-19 |
5,751 |
2021-03-19 |
50,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VTGN |
Vistagen Therapeutics Inc |
|
|
2021-03-19 |
4 |
OE |
$1.50 |
$3,750 |
D/D |
2,500 |
5,751 |
0 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2020-08-21 |
4 |
B |
$0.69 |
$20,700 |
I/I |
30,000 |
50,000 |
0.01 |
% |
|
DRRX |
Durect Corp |
Director |
|
2019-06-10 |
4 |
B |
$0.54 |
$13,750 |
I/I |
25,000 |
150,000 |
2.1 |
- |
|
DRRX |
Durect Corp |
Director |
|
2019-05-24 |
4 |
B |
$0.63 |
$18,903 |
I/I |
30,000 |
125,000 |
2.1 |
- |
|
DRRX |
Durect Corp |
Director |
|
2019-05-13 |
4 |
B |
$0.70 |
$6,773 |
I/I |
9,600 |
95,000 |
2.1 |
- |
|
DRRX |
Durect Corp |
Director |
|
2019-05-13 |
4 |
B |
$0.68 |
$28,095 |
I/I |
40,400 |
85,400 |
2.1 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2019-03-14 |
4 |
B |
$1.27 |
$10,086 |
I/I |
7,920 |
20,000 |
0.01 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2019-03-13 |
4 |
B |
$1.26 |
$15,201 |
I/I |
12,080 |
12,080 |
0.01 |
- |
|
DRRX |
Durect Corp |
Director |
|
2019-03-13 |
4 |
B |
$0.82 |
$3,021 |
I/I |
3,700 |
45,000 |
2.1 |
- |
|
DRRX |
Durect Corp |
Director |
|
2019-03-13 |
4 |
B |
$0.82 |
$17,480 |
I/I |
21,300 |
41,300 |
2.1 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2019-01-29 |
4 |
OE |
$1.50 |
$2,063 |
D/D |
1,375 |
3,251 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2017-10-13 |
4 |
D |
$11.18 |
$1,509,300 |
D/D |
(135,000) |
0 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2017-02-22 |
4 |
OE |
$2.61 |
$33,147 |
D/D |
12,700 |
135,000 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2017-02-16 |
4 |
OE |
$2.61 |
$45,153 |
D/D |
17,300 |
122,300 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2016-01-04 |
4 |
OE |
$2.46 |
$73,800 |
D/D |
30,000 |
105,000 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2015-03-04 |
4 |
OE |
$3.27 |
$98,100 |
D/D |
30,000 |
75,000 |
0 |
- |
|
DRRX |
Durect Corp |
Director |
|
2012-12-12 |
4 |
B |
$0.91 |
$13,619 |
D/D |
15,000 |
27,810 |
2.39 |
- |
|
DRRX |
Durect Corp |
Director |
|
2012-08-28 |
4 |
B |
$0.98 |
$4,900 |
D/D |
5,000 |
12,810 |
2.31 |
- |
|
DRRX |
Durect Corp |
Director |
|
2012-08-27 |
4 |
B |
$0.96 |
$2,698 |
D/D |
2,810 |
7,810 |
2.31 |
- |
|
DRRX |
Durect Corp |
Director |
|
2012-08-23 |
4 |
B |
$1.00 |
$5,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2012-05-02 |
4 |
OE |
$3.84 |
$76,800 |
D/D |
20,000 |
45,000 |
0 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2011-12-14 |
4 |
OE |
$1.25 |
$3,480 |
D/D |
2,784 |
20,138 |
0 |
- |
|
SCLN |
Sciclone Pharmaceuticals ... |
Director |
|
2011-05-20 |
4 |
OE |
$5.26 |
$52,600 |
D/D |
10,000 |
25,000 |
0 |
- |
|
VTGN |
Vistagen Therapeutics Inc |
|
|
2011-05-11 |
4 |
A |
$3.50 |
$60,739 |
D/D |
17,354 |
17,354 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Director |
|
2008-04-09 |
4 |
OE |
$4.25 |
$510,000 |
D/D |
120,000 |
421,680 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|